Table 5.
Comparison of participants with and without central nervous system involvement according to the presence of neuropathic pain (according to PDQ and LANSS)
| PDQ | LANSS | |||||
|---|---|---|---|---|---|---|
| Negative (%) | Suspect/positive (%) | p* | No (%) | Yes (%) | p* | |
| Headache | 0.710 | |||||
| Yes (n=124) | 92.7 | 7.3 | 0.367 | 96.8 | 3.2 | |
| No (n=85) | 96.5 | 3.5 | 97.6 | 2.4 | ||
| Thromboembolism | 0.728 | |||||
| Yes (n=4) | 100 | 0 | 0.618 | 100 | 0 | |
| No (n=205) | 94.1 | 5.9 | 97.1 | 2.9 | ||
| Loss of taste or smell | 0.441 | |||||
| Yes (n=106) | 93.4 | 6.6 | 0.587 | 98.1 | 1.9 | |
| No (n=103) | 95.1 | 4.9 | 96.1 | 3.9 | ||
| Depression | 0.764 | |||||
| Yes (n=3) | 100 | 0 | 0.667 | 100 | 0 | |
| No (n=206) | 94.2 | 5.89 | 97.1 | 2.9 | ||
LANSS: Leeds assessment of neuropathic symptoms and signs; PDQ: Pain-DETECT questionnaire; *: Chi-square analysis was performed: p=Statistically significant.